Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ReposiTrak's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ReposiTrak's regulatory disclosures and financial reporting.
ReposiTrak, Inc. has entered into stock purchase agreements to acquire 4,709,837 shares of SPAR Group common stock for aggregate contingent consideration of about $3.3 million. Consideration includes a $100,000 non-refundable deposit, cash payments of $139,883 and $485,118, and an unsecured promissory note.
The note to William Bartels has a principal amount of $2,571,885, bears 6.0% annual interest, and matures on July 1, 2030, with three annual principal installments of $725,000 plus interest and the balance due at maturity. Following delivery of the shares, ReposiTrak will beneficially own 31.3% of SPAR Group’s outstanding common stock but does not receive contractual rights to direct SPAR Group’s management or operations.
ReposiTrak, Inc. has declared a quarterly cash dividend of $0.02 per share, or $0.08 per share on an annual basis, on its common stock. The dividend is payable on or about August 14, 2026 to stockholders of record as of June 30, 2026.
The company also stated that subsequent dividends are expected to be paid within 45 days of each fiscal quarter end, signaling an ongoing quarterly dividend program, although future payments remain subject to the usual forward-looking risks noted in its disclosures.
ReposiTrak, Inc. disclosed an amendment to its services agreement with SPAR Group, Inc. that changes how it can be paid for services. Instead of only cash, ReposiTrak may now receive cash, SPAR Group common stock, or a mix of both for work performed under the agreement.
ReposiTrak elected to take stock for the outstanding balance, receiving 3,190,569 shares of SPAR Group common stock at a deemed value of $0.728710119 per share, in lieu of a $2,325,000 cash payment. This converts a service receivable into an equity position in its client while leaving the underlying one-year services arrangement otherwise in place.
ReposiTrak, Inc. reported solid third-quarter fiscal 2026 results, with revenue essentially flat at $5.9 million while profitability improved meaningfully. Total operating expenses fell 12% to $3.6 million, lifting income from operations 24% to about $2.3 million. GAAP net income was roughly $2.0 million, and diluted earnings per share were $0.10, in line with last year.
For the first nine months of fiscal 2026, revenue increased 5% to $17.7 million, operating expenses declined 4% to $11.7 million, and GAAP net income rose 6% to $5.5 million. Diluted EPS grew 9% to $0.28. The company ended the quarter with $26.4 million in cash and no bank debt, while returning capital through buybacks, preferred redemptions, and a quarterly dividend of $0.02 per share.
Management highlighted that more than 98% of revenue now comes from recurring SaaS contracts, with net margins above 30%. Strategically, ReposiTrak filed two new patents around its Touchless Traceability solution and data integrity tools, and advanced a collaboration with SPAR Group to pair its supply chain analytics with in-store execution services, aiming to extend its end-to-end food safety and merchandising platform.
ReposiTrak, Inc. reported stable results for the quarter ended March 31, 2026, with revenue of $5.9 million, down 1% year over year, and quarterly net income of $2.0 million. Higher-margin recurring subscription revenue and lower expenses lifted income from operations to $2.3 million.
For the nine months, revenue rose 5% to $17.7 million and net income reached $5.5 million, while diluted EPS increased to $0.28. The company ended the period with cash of $26.4 million, positive working capital of $26.3 million, and no bank debt.
ReposiTrak continued capital returns, including common share repurchases and ongoing redemption of its Series B preferred stock, leaving $1.72 million of preferred value outstanding. The board also declared a quarterly dividend of $0.02 per share. The company entered a new $3.0 million unsecured note receivable at an 8% rate with potential equity-linked return features.
ReposiTrak, Inc. Schedule 13G filed by Ashford Capital Management, Inc. reports beneficial ownership of 1,014,028 shares of common stock, representing 5.57% of the class based on February 17, 2026 outstanding share count. The filing states these shares are held across separate client accounts, three limited partnerships, and one commingled fund.
Handelsbanken Fonder filed an amendment to Schedule 13G/A reporting no beneficial ownership of ReposiTrak, Inc. common stock. The filing states 0 shares beneficially owned, representing 0% of the class, and affirms the filer holds ownership of 5 percent or less. The filing is signed by Emma Viotti, Managing Director with a signature date of 04/27/2026.
ReposiTrak, Inc. declared a quarterly cash dividend of $0.02 per share, or $0.08 per share annually, on its common stock. The dividend is payable on or about May 15, 2026 to stockholders of record on March 31, 2026. The company expects subsequent dividends to be paid within 45 days after each fiscal quarter end.
ReposiTrak, Inc.’s Form 4 shows an open-market sale of 7,500 shares of Common Stock at a weighted average price of $8.0596 per share. The sale was made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan to help meet charitable commitments.
After this transaction, that LLC holds 70,000 ReposiTrak shares indirectly for Randall K. Fields. The filing also reports Fields directly owning 3,483,955 Common shares, along with additional indirect holdings, including 615,260 Common shares via Riverview Financial Corp., 333,643 via Fields Management, Inc., and related Series B Preferred Stock positions.
ReposiTrak, Inc. director James R. Gillis filed a Form 3, which is an initial statement of beneficial ownership of company securities. This filing simply establishes his status as an insider and does not report any stock purchases, sales, option exercises, or other transactions.